Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones| (NYSE: RCUS) | Delayed: 26.15 -2.34 (8.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.49 | 52 Week High | $ | |||
| Open | $28.02 | 52 Week Low | $ | |||
| Day High | $28.46 | P/E | N/A | |||
| Day Low | $25.91 | EPS | $ | |||
| Volume | 2,391,100 | |||||
